BACKGROUND: The incidence and risk factors of carotid artery stenosis in asymptomatic patients after head and neck radiation therapy (RT) are unknown. METHODS: This retrospective study reviewed asymptomatic patients treated with RT for head and neck cancer from 2000 to 2009 who underwent screening carotid ultrasound. RESULTS: Two hundred twenty-four patients were included, the majority of whom had stage III to IV disease and received cisplatin-based chemotherapy. Median time from RT completion to last carotid ultrasound was 3 years. Actuarial rate of carotid artery stenosis at 4 years was 14% (95% confidence interval [CI], 4% to 22%). Multivariate analysis revealed that carotid artery stenosis was associated with Framingham risk factors (hazard ratio [HR], 1.6 per factor; 95% CI, 1.2-2.2; p = .003). Among 135 patients treated with intensity-modulated radiation therapy (IMRT), the HR for carotid artery stenosis was 1.4 for every 10 Gy increase in mean RT dose to the carotid bulb plus 2 cm (95% CI, 0.8-2.4; p = .35). CONCLUSION: Prevention and screening programs should be considered for head and neck cancer survivors given the high risk of carotid artery stenosis.
BACKGROUND: The incidence and risk factors of carotid artery stenosis in asymptomatic patients after head and neck radiation therapy (RT) are unknown. METHODS: This retrospective study reviewed asymptomatic patients treated with RT for head and neck cancer from 2000 to 2009 who underwent screening carotid ultrasound. RESULTS: Two hundred twenty-four patients were included, the majority of whom had stage III to IV disease and received cisplatin-based chemotherapy. Median time from RT completion to last carotid ultrasound was 3 years. Actuarial rate of carotid artery stenosis at 4 years was 14% (95% confidence interval [CI], 4% to 22%). Multivariate analysis revealed that carotid artery stenosis was associated with Framingham risk factors (hazard ratio [HR], 1.6 per factor; 95% CI, 1.2-2.2; p = .003). Among 135 patients treated with intensity-modulated radiation therapy (IMRT), the HR for carotid artery stenosis was 1.4 for every 10 Gy increase in mean RT dose to the carotid bulb plus 2 cm (95% CI, 0.8-2.4; p = .35). CONCLUSION: Prevention and screening programs should be considered for head and neck cancer survivors given the high risk of carotid artery stenosis.
Authors: Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K S Clifford Chao; Christopher J Schultz; Nancy Lee; Karen K Fu Journal: N Engl J Med Date: 2004-05-06 Impact factor: 91.245
Authors: Joseph D Martin; Anne R Buckley; Doug Graeb; Brenda Walman; Anthony Salvian; John H Hay Journal: Int J Radiat Oncol Biol Phys Date: 2005-06-22 Impact factor: 7.038
Authors: Paul D Brown; Robert L Foote; Mark P McLaughlin; Michele Y Halyard; Karla V Ballman; A Craig Collie; Robert C Miller; Kelly D Flemming; John W Hallett Journal: Int J Radiat Oncol Biol Phys Date: 2005-09-19 Impact factor: 7.038
Authors: Scott R Steele; Matthew J Martin; Philip S Mullenix; James V Crawford; Daniel S Cuadrado; Charles A Andersen Journal: Am J Surg Date: 2004-05 Impact factor: 2.565
Authors: Grace L Smith; Benjamin D Smith; Thomas A Buchholz; Sharon H Giordano; Adam S Garden; Wendy A Woodward; Harlan M Krumholz; Randal S Weber; K-Kian Ang; David I Rosenthal Journal: J Clin Oncol Date: 2008-08-25 Impact factor: 44.544
Authors: Tracy Wolff; Janelle Guirguis-Blake; Therese Miller; Michael Gillespie; Russell Harris Journal: Ann Intern Med Date: 2007-12-18 Impact factor: 25.391
Authors: David J Carpenter; Yvonne M Mowery; Gloria Broadwater; Anna Rodrigues; Amy J Wisdom; Jennifer A Dorth; Pretesh R Patel; Cynthia K Shortell; Robert Clough; David M Brizel Journal: Oral Oncol Date: 2018-03-14 Impact factor: 5.337
Authors: Verónica Fernández-Alvarez; Fernando López; Carlos Suárez; Primoz Strojan; Avraham Eisbruch; Carl E Silver; William M Mendenhall; Johannes A Langendijk; Alessandra Rinaldo; Anne W M Lee; Jonathan J Beitler; Robert Smee; Javier Alvarez; Alfio Ferlito Journal: Strahlenther Onkol Date: 2018-04-20 Impact factor: 3.621
Authors: Christian C Okoye; Jessica Bucher; Curtis Tatsuoka; Sahil A Parikh; Guilherme H Oliveira; Michael K Gibson; Mitchell Machtay; Min Yao; Chad A Zender; Jennifer A Dorth Journal: Head Neck Date: 2016-12-29 Impact factor: 3.147
Authors: Bennett G Childs; Martina Gluscevic; Darren J Baker; Remi-Martin Laberge; Dan Marquess; Jamie Dananberg; Jan M van Deursen Journal: Nat Rev Drug Discov Date: 2017-07-21 Impact factor: 84.694
Authors: K Garcez; C C Lim; P Whitehurst; D Thomson; K F Ho; M Lowe; A Sykes; L W Lee; B Yap; N Slevin Journal: Br J Radiol Date: 2014-02-17 Impact factor: 3.039
Authors: D Strüder; S Hellwig; H Rennau; S van Bonn; S P Schraven; R Mlynski; G Hildebrandt; T Schuldt Journal: Eur Arch Otorhinolaryngol Date: 2020-09-01 Impact factor: 2.503